EUIPO trademark

GOMOSDI

RegisteredEUIPOWord markClass 5

"GOMOSDI" is a word mark owned by Teva Pharmaceuticals USA, Inc., filed at the EUIPO on October 30, 2024. It is registered and covers class 5 (Pharmaceuticals).

View Teva Pharmaceuticals USA, Inc. portfolioGet this data via the API
Official EUIPO record
GOMOSDI
Word mark as filed with the EUIPO
Status
Registered
Since March 20, 2025
Filed
October 30, 2024
Registered
March 19, 2025
Expires
October 30, 2034
Application no.
019098808
Registration no.
019098808
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns GOMOSDI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Teva Pharmaceuticals USA, Inc.

648 trademarks in the portfolioView company

Representative

D Young & Co LLP

D Young & Co LLP

Goods and services

What the mark covers

The products and services GOMOSDI is filed for, grouped by Nice class.

  • Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

History

What has happened so far

Steps recorded by the EUIPO, newest first.

  1. Bulletin 2025/101 Section C.2.1
  2. Bulletin 2025/054 Section B.1
  3. Bulletin 2024/236 Section A.1
FAQ

About GOMOSDI

Who owns the trademark "GOMOSDI"?

The EUIPO trademark "GOMOSDI" (application 019098808) is owned by Teva Pharmaceuticals USA, Inc.

What is the status of "GOMOSDI"?

Its status at the EUIPO is: registered.

When was "GOMOSDI" registered?

It was registered on March 19, 2025 and is due to expire on October 30, 2034.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull GOMOSDI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d46db-855d-73bc-9061-73ffaf0114d8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d46db-855d-73bc-9061-73ffaf0114d8",
  "object": "trademark",
  "mark_text": "GOMOSDI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "EM",
  "application_number": "019098808",
  "filing_date": "2024-10-30",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "TEVA PHARMACEUTICALS USA, Inc.",
      "entity_id": "ent_019fc41c-ecc5-76e9-863d-e500c53224ec"
    }
  ]
}